Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.78Price to Sales
VS
Market
Sector
Industry
History
$ 0.64Close
$ 0.43 - $ 2.87 52-Week Range
Ticker Information
Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSANGAMO THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SGMO - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 145.73M | 1.78 | $ 81.71M |
| 3/31/2025 | $ 174.18M | 2.73 | $ 63.76M |
| 12/31/2024 | $ 226.96M | 3.93 | $ 57.8M |
| 9/30/2024 | $ 565.43M | 10.81 | $ 52.29M |
| 6/30/2024 | $ 206.14M | 16.79 | $ 12.28M |
| 3/31/2024 | $ 108.53M | 5.79 | $ 18.76M |
| 12/31/2023 | $ 140.44M | 0.8 | $ 176.23M |
| 9/30/2023 | $ 104.81M | 0.52 | $ 201.42M |
| 6/30/2023 | $ 201.91M | 0.92 | $ 218.48M |
| 3/31/2023 | $ 218.22M | 0.91 | $ 241.03M |
Key Performance Insights, Last 5 Years
- SANGAMO THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 11.35.
- Over the past 5 years, SANGAMO THERAPEUTICS INC's average P/S has been 6.96.
- The median P/S for SANGAMO THERAPEUTICS INC during this period was 5.93
- SANGAMO THERAPEUTICS INC reached its highest P/S over the past 5 years at 16.79.
- The lowest P/S recorded by SANGAMO THERAPEUTICS INC in the same timeframe 0.52
SANGAMO THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for SANGAMO THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.67B ] / Revenues [ $ 147.24M ]
(=) P/S [ 11.35 ] SGMO - Price to Sales, Last 5 years
0.52
Minimum
Sep 30, 2023
16.79
Maximum
Jun 30, 2024
6.96
Average
5.93
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |